Kestra Private Wealth Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692K | Sell |
18,013
-1,085
| -6% | -$41.7K | 0.01% | 893 |
|
|
2025
Q1 | $740K | Buy |
19,098
+5,968
| +45% | +$231K | 0.01% | 794 |
|
|
2024
Q4 | $444K | Sell |
13,130
-4,071
| -24% | -$138K | 0.01% | 972 |
|
|
2024
Q3 | $703K | Sell |
17,201
-26,919
| -61% | -$1.1M | 0.01% | 748 |
|
|
2024
Q2 | $1.7M | Buy |
44,120
+17,140
| +64% | +$660K | 0.03% | 433 |
|
|
2024
Q1 | $1.16M | Buy |
26,980
+8,932
| +49% | +$383K | 0.03% | 518 |
|
|
2023
Q4 | $669K | Sell |
18,048
-7,706
| -30% | -$286K | 0.02% | 631 |
|
|
2023
Q3 | $934K | Buy |
25,754
+4,101
| +19% | +$149K | 0.03% | 486 |
|
|
2023
Q2 | $772K | Buy |
21,653
+2,433
| +13% | +$86.7K | 0.03% | 503 |
|
|
2023
Q1 | $684K | Buy |
19,220
+8,081
| +73% | +$288K | 0.03% | 508 |
|
|
2022
Q4 | $391K | Buy |
11,139
+694
| +7% | +$24.4K | 0.02% | 588 |
|
|
2022
Q3 | $307K | Buy |
10,445
+192
| +2% | +$5.64K | 0.02% | 643 |
|
|
2022
Q2 | $558K | Sell |
10,253
-6,163
| -38% | -$335K | 0.03% | 469 |
|
|
2022
Q1 | $894K | Buy |
16,416
+5,166
| +46% | +$281K | 0.04% | 404 |
|
|
2021
Q4 | $620K | Buy |
11,250
+2,900
| +35% | +$160K | 0.03% | 521 |
|
|
2021
Q3 | $399K | Buy |
8,350
+793
| +10% | +$37.9K | 0.02% | 604 |
|
|
2021
Q2 | $376K | Sell |
7,557
-2,469
| -25% | -$123K | 0.02% | 591 |
|
|
2021
Q1 | $447K | Buy |
10,026
+1,140
| +13% | +$50.8K | 0.03% | 480 |
|
|
2020
Q4 | $411K | Buy |
8,886
+2,172
| +32% | +$100K | 0.03% | 477 |
|
|
2020
Q3 | $316K | Buy |
+6,714
| New | +$316K | 0.03% | 474 |
|